Archief Roodbont

dabigatran

SUMMARY AND COMMENT

Dabigatran: How Safe?

July 31, 2012 | David Green, MD, PhD

Within 12 weeks of marketing approval, dabigatran was found to be responsible for more adverse events than nearly all other medications.

Reviewing: Radecki RP. Ann Intern Med 2012 Jul 3; 157:66